No Data
No Data
Insiders Hold 65% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and They've Been Buying Recently
Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
Nuvectis Pharma(NVCT.US) 10% Shareholder Buys US$13,075.6 in Common Stock
Nuvectis Pharma(NVCT.US) 10% Shareholder Buys US$12,800 in Common Stock
Nuvectis Pharma(NVCT.US) Officer Buys US$3,145 in Common Stock
No Data